Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Diethyl Hydrogen Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | MVD | P53602 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethyl Hydrogen Phosphate SCHEMBL28596733 | 0.97 | TSHR (0.43) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL31065172 | 0.92 | TSHR (0.48) | TSHRPPARDTP53TDP1CA12 | |
| Acetic Acid SCHEMBL28479624 | 0.89 | PPARD (0.38) | TSHRPPARDCA12CA1CA2 | |
| Diethyl Hydrogen Phosphate SCHEMBL27873282 | 0.89 | PPARD (0.38) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL27294237 | 0.89 | TSHR (0.56) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL93056 | 0.89 | — | — | |
| Diethyl Hydrogen Phosphate SCHEMBL27873286 | 0.87 | TSHR (0.43) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL697968 | 0.86 | PPARD (0.39) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL906759 | 0.86 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL8431810 | 0.86 | TSHR (0.53) | TSHRPPARDTP53TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122025690-A | Composite modified material of high-toughness graphite bipolar plate and preparation method thereof | 青岛高等密封制品有限公司 | 2026-05-12 | — | — | CN | disclosed |
| WO-2022088573-A1 | METHOD FOR PREPARING PYROTINIB | 苏州富士莱医药股份有限公司 | 2022-05-05 | — | — | WO | disclosed |
| CN-112358467-B | Preparation process of pyrroltinib | 苏州富士莱医药股份有限公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-112279838-B | Preparation method of pyrroltinib | 苏州富士莱医药股份有限公司 | 2021-07-13 | — | — | CN | disclosed |
| CN-112358467-A | Preparation process of pyrroltinib | 苏州富士莱医药股份有限公司 | 2021-02-12 | — | — | CN | disclosed |
| CN-112279838-A | Preparation method of pyrroltinib | 苏州富士莱医药股份有限公司 | 2021-01-29 | — | — | CN | disclosed |
| CN-105884831-A | Preparation method of phorate pesticide hapten and application of phorate pesticide hapten | 江苏师范大学 | 2016-08-24 | — | — | CN | disclosed |
| CN-102448458-B | Methods and compositions for treating flaviviridae virus infections | UNIV LELAND STANFORD JUNIOR | 2015-07-22 | — | — | CN | disclosed |
| US-8975247-B2 | Methods and compositions of treating a flaviviridae family viral infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNION UNIVERSITY (US) | 2015-03-10 | — | — | US | disclosed |
| EP-2699096-A2 | METHOD FOR MOSQUITO CONTROL | Dobson, Stephen (US) | 2014-02-26 | — | — | EP | disclosed |
| US-20120276050-A1 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-11-01 | — | — | US | disclosed |
| WO-2012145145-A2 | METHOD FOR MOSQUITO CONTROL | DOBSON STEPHEN (US) | 2012-10-26 | — | — | WO | disclosed |
| CN-102448458-A | Methods and compositions for treating flaviviridae virus infections | UNIV LELAND STANFORD JUNIOR | 2012-05-09 | — | — | CN | disclosed |
| EP-2408449-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | The Board Of Trustees Of The University Of the Leland Stanford Junior University (US) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010107739-A2 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276050-A1 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION | NSUN3, RNGTT, NSUN2 | TSHR 4438/4885PPARD 2491/4885TP53 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.